Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial
Diabetes/Metabolism Research and Reviews. 23:386-391
ISSN:
1520-7560 1520-7552
DOI:
10.1002/dmrr.708
Popis:
Background Recently, high prevalence of exocrine dysfunction in diabetic populations has been reported. Patients with fecal elastase 1 concentration (FEC)